Previous studies have shown that the AKT/mTOR signalling pathway is involved in the occurrence, development and chemoresistance of gliomas (Murphy et al., 2016; Lo Dico et al., 2019; Tang et al., 2022). This evidence concerns the gene AKT1 and glioma.